Key facts
- This page summarizes Scott Schlackman's Form 4 filing for MEDIFAST INC (MED).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Mar 2024, 17:18.
Scott Schlackman - 08 Mar 2024 Form 4 Insider Report for MEDIFAST INC (MED)
- Reporting relationship
- Director
- Issuer ticker
- MED
- Reported as of
- 08 Mar 2024
- Net transaction value
- -$123,882
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2024, 17:18:26 UTC
- Prior SEC filing
- 09 Nov 2023
- Next SEC filing
- 24 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason L. Groves, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scott Schlackman filed Form 4 for MEDIFAST INC (MED) on 12 Mar 2024.
Change
- Previous filing in this sequence was filed on 09 Nov 2023.
- Current net transaction value: -$123,882.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MED
transaction
Common Stock
Options Exercise
- Transaction value
- $35,984
- Shares
- +1,300
- Change %
- +12%
- Price
- $27.68
- Shares after
- 11,838
- Date
- 08 Mar 2024
- Ownership
- Direct
MED
transaction
Common Stock
Sale
- Transaction value
- $51,233
- Shares
- -1,300
- Change %
- -11%
- Price
- $39.41
- Shares after
- 10,538
- Date
- 08 Mar 2024
- Ownership
- Direct
MED
transaction
Common Stock
Sale
- Transaction value
- $108,633
- Shares
- -2,753
- Change %
- -26%
- Price
- $39.46
- Shares after
- 7,785
- Date
- 08 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MED
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,300
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 08 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,300
- Exercise price
- $27.68
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
Footnote F2
The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.